Distribution model change
GSK UK Pharmaceuticals and ViiV Healthcare are changing the way we distribute medicines and vaccines in the UK from the current direct to pharmacy model to a reduced wholesaler model. The change will take place on the 1st November 2018.
Please see the below appropriate attachment for more info.
Boostrix-IPV (Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)) will be available to order from the end of February 2019
Note : Vaccines for the UK national immunisation programme should be ordered as normal via Immform
Divested and discontinued products
> Hepatyrix vaccines PFS
> Typherix vaccines PFS
> Trimovate cream 30gm - divested to Ennogen Healthcare
> Warticon cream 0.15% - divested to Pheonix Labs
> Warticon solution 0.5% - divested to Phoenix Labs